98%
921
2 minutes
20
Background: Norovirus is the leading cause of viral gastroenteritis worldwide, contributing to widespread disease and financial burdens. However, current testing methods are unsuitable for on-site analysis, as they typically use biological receptors, require specialized reagents, and skilled technicians. Proactive on-site testing of high-risk food samples is essential to prevent outbreaks, requiring the development of innovative sensor systems.
Results: We have developed a thermal sensor capable of selectively detecting two recurrent norovirus genotypes, GI.1 and GII.4, within a model food matrix. The sensor uses epitope-imprinted polymer nanoparticles (nanoMIPs) designed from a 10-amino-acid sequence derived from the conserved P1 region of the GI.1 viral capsid. The nanoMIPs demonstrated favorable detection capability to norovirus GI.1 and GII.4 virus-like particles in buffer solutions, achieving detection limits of 1.53 and 2.28 pg/mL, respectively. The selectivity of the nanoMIPs was evaluated against a panel of similar viruses, including murine norovirus, Tulane virus, and bacteriophage MS2, each of which showed a reduced signal. Notably, the sensor achieved rapid detection (30 min) of norovirus GI.1 and GII.4 virus-like particles in contamination prone spinach samples while maintaining comparable detection limits (2.19 pg/mL and 2.69 pg/mL) to spiked buffer solutions.
Significance: The combination of rapid detection time, dual strain recognition, and simple sample preparation makes this thermal sensor a promising tool for on-site testing in food safety and public health settings. Furthermore, the ability to detect multiple strains using a single ligand represents a significant advantage, enabling the development of straightforward systems capable of detecting various strains in complex environments.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.aca.2025.344331 | DOI Listing |
Bioorg Med Chem Lett
July 2018
Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address:
A series of tripeptidyl transition state inhibitors with new P1 and warhead moieties were synthesized and evaluated in a GI-1 norovirus replicon system and against GII-4 and GI-1 norovirus proteases. Compound 19, containing a 6-membered ring at the P1 position and a reactive aldehyde warhead exhibited sub-micromolar replicon inhibition. Retaining the same peptidyl scaffold, several reactive warheads were tested for protease inhibition and norovirus replicon inhibition.
View Article and Find Full Text PDFJ Med Virol
July 2014
Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Norovirus (NoV) and Sapovirus (SaV) have been reported as a common cause of acute gastroenteritis worldwide. For a decade, surveillances of NoV and SaV have been conducted continually in Thailand. To monitor the epidemiological situation and to determine the genetic variation of NoV and SaV in Chiang Mai, Thailand, 567 samples collected from pediatric patients hospitalized with acute gastroenteritis were examined during 2007, and 2010-2011 by semi-nested RT-PCR and nucleotide sequencing methods.
View Article and Find Full Text PDFBMC Infect Dis
September 2013
Department of Infectious diseases and Gastroenterology, Children's Hospital of Chongqing Medical University, No, 136 Zhongshan Er Road, Yuzhong District, Chongqing 400014, China.
Background: Enteric viruses are a major cause of diarrhea in children, especially those <5 years old. Identifying the viral agents is critical to the development of effective preventive measures. This study aimed to determine the prevalence of common enteric viruses in children <5 years old presented with diarrhea to the Children's Hospital of Chongqing Medical University.
View Article and Find Full Text PDFPLoS One
April 2014
Vaccine Research Center, University of Tampere School of Medicine, Tampere, Finland.
Rotavirus (RV) and norovirus (NoV) are the two major causes of viral gastroenteritis (GE) in children worldwide. We have developed an injectable vaccine design to prevent infection or GE induced with these enteric viruses. The trivalent combination vaccine consists of NoV capsid (VP1) derived virus-like particles (VLPs) of GI-3 and GII-4 representing the two major NoV genogroups and tubular RV recombinant VP6 (rVP6), the most conserved and abundant RV protein.
View Article and Find Full Text PDFArch Virol
November 2013
Department of Infectious Diseases, Qilu Hospital, Shandong University, Wenhua Xi Road 107, Jinan, 250012, Shandong, China.
Acute gastroenteritis caused by human noroviruses (NoVs) has become an important public health problem worldwide. This study was carried out to investigate the rates of NoV infections and the genetic characteristics of NoVs in adult outpatients with acute gastroenteritis in Ji'nan, a large eastern city in China. A total of 480 fecal samples were collected from outpatients at the Shandong University Qilu Hospital between June 2010 and May 2011.
View Article and Find Full Text PDF